Journal of Inflammatory Diseases
The Official Journal of Qazvin University of Medical Sciences
Epidemiological assessment of re-treatment pulmonary tuberculosis patients (Tehran, 1999)
Abstract
Abstract Background: WHO divides tuberculosis into four categories according to involvement and treatment history: new patients with positive sputum and extra pulmonary as first category, re-treatment patients as second category, pulmonary tuberculosis with negative sputum as third category, and chronic tuberculosis with positive sputum as forth category. Objective: This research was conducted to determine the epidemiological assessment of re-treatment pulmonary tuberculosis patients in Daneshvary hospital, Tehran. Methods: The research was a cross-sectional study in nature. In this study 292 medical records were evaluated, consisting of 261 cases of new positive smear and 31 cases of re-treatment patients. All patients were registered during 1999. Results: Of 292 positive sputum patients, 31 (11%) was re-treatment patients. About 35% classified as relapse cases, 10% as defaulters and 55% as failures. The percentage of cured patients in defaulters was more and in failures was less than other classes. Conclusion: As the strongest risk factor associated with relapse is poor treatment, the strongest risk factor associated with default is disorganization and unavailability to health services and the strongest risk factor associated with failure is drug indication and drug resistance, more attention is appropriate for responsible organs.
Copyright
© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
A Seven Year Retrospective Study on Epidemiology and Clinical Characteristics of Tuberculosis in Iran
Bayat S, Gol-Mohamadi A, Sarbazi MR, Safaee A, Farsar AR. A Seven Year Retrospective Study on Epidemiology and Clinical Characteristics of Tuberculosis in Iran. Arch Clin Infect Dis. 2013;8(2):ee14505. doi: https://doi.org/10.5812/archcid.14505
Epidemiology of tuberculosis in Arak, Iran
Sofian M, zarinfar N, Mirzaie M, MosaviNezhad A. Epidemiology of tuberculosis in Arak, Iran. koomesh. 2009;10(4):e152250. doi:
Challenges of Tuberculosis in Iran
Zahedi Bialvaei A, Asgharzadeh M, Aghazadeh M, Nourazarian M, Samadi Kafil H. Challenges of Tuberculosis in Iran. Jundishapur J Microbiol. 2017;10(3):e37866. doi: https://doi.org/10.5812/jjm.37866
The Follow-up of 360 Patients with Pulmonary Tuberculosis After 2 Months Treatment With Anti-tubercular Agents in Iran
Kazerani M, Kazerani M, Ashrafzadeh K, Rahiman S, Mottaghy M, et al. The Follow-up of 360 Patients with Pulmonary Tuberculosis After 2 Months Treatment With Anti-tubercular Agents in Iran. Arch Clin Infect Dis. 2018;13(4):e62132. doi: https://doi.org/10.5812/archcid.62132
Epidemiologic Consideration of Tuberculosis in East Health Center of Ahvaz in 2010
Yahyavi M, Karimi Z, Falsafizadeh S, Noori M, Hosinzadeh F, et al. Epidemiologic Consideration of Tuberculosis in East Health Center of Ahvaz in 2010. Jundishapur J Chronic Dis Care. 2014;3(1):32261. doi:
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 0
Last Update: 3 weeks ago
- Scopus by Title (Ref): 1
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 1 day ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC